Comprehensive T cell repertoire characterization of non-small cell lung cancer
Alexandre Reuben,Jiexin Zhang,Shin-Heng Chiou,Rachel M. Gittelman,Jun Li,Won-Chul Lee,Junya Fujimoto,Carmen Behrens,Xiaoke Liu,Feng Wang,Kelly Quek,Chunlin Wang,Farrah Kheradmand,Runzhe Chen,Chi-Wan Chow,Heather Lin,Chantale Bernatchez,Ali Jalali,Xin Hu,Chang-Jiun Wu,Agda Karina Eterovic,Edwin Roger Parra,Erik Yusko,Ryan Emerson,Sharon Benzeno,Marissa Vignali,Xifeng Wu,Yuanqing Ye,Latasha D. Little,Curtis Gumbs,Xizeng Mao,Xingzhi Song,Samantha Tippen,Rebecca L. Thornton,Tina Cascone,Alexandra Snyder,Jennifer A. Wargo,Roy Herbst,Stephen Swisher,Humam Kadara,Cesar Moran,Neda Kalhor,Jianhua Zhang,Paul Scheet,Ara A. Vaporciyan,Boris Sepesi,Don L. Gibbons,Harlan Robins,Patrick Hwu,John V. Heymach,Padmanee Sharma,James P. Allison,Veera Baladandayuthapani,Jack J. Lee,Mark M. Davis,Ignacio I. Wistuba,P. Andrew Futreal,Jianjun Zhang
DOI: https://doi.org/10.1038/s41467-019-14273-0
IF: 16.6
2020-01-30
Nature Communications
Abstract:Abstract Immunotherapy targeting T cells is increasingly utilized to treat solid tumors including non-small cell lung cancer (NSCLC). This requires a better understanding of the T cells in the lungs of patients with NSCLC. Here, we report T cell repertoire analysis in a cohort of 236 early-stage NSCLC patients. T cell repertoire attributes are associated with clinicopathologic features, mutational and immune landscape. A considerable proportion of the most prevalent T cells in tumors are also prevalent in the uninvolved tumor-adjacent lungs and appear specific to shared background mutations or viral infections. Patients with higher T cell repertoire homology between the tumor and uninvolved tumor-adjacent lung, suggesting a less tumor-focused T cell response, exhibit inferior survival. These findings indicate that a concise understanding of antigens and T cells in NSCLC is needed to improve therapeutic efficacy and reduce toxicity with immunotherapy, particularly adoptive T cell therapy.
multidisciplinary sciences